Aclaris Therapeutics (ACRS) reported Q4 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. META
6. SPY
7. ACN
8. NVDA
9. PRIM
10. PFE

Go back to Aclaris Therapeutics (ACRS) reported Q4 Revenue
(NASDAQ: ACRS) Delayed: 4.98 +0.14 (2.89%)
Previous Close $4.84    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $5.12    P/E N/A 
Day Low $4.77    EPS $0.00 
Volume 942,813